1 Min Read |
JERUSALEM, Feb 4 (Reuters) –
* Israeli flavours and ingredients maker Frutarom Industries Ltd said on Sunday it bought 100 percent of Israeli Biotech Research (IBR) for $21 million in a deal financed through bank debt.
* It was the first acquisition of the year for Frutarom after buying 12 companies in 2017. It has made 32 acquisitions since 2015.
* IBR develops, manufactures and markets natural active ingredients for the cosmetics and dietary supplements industries. It had sales of $7.4 million in 2017.
* “The IBR acquisition is … an important step in implementing Frutarom’s strategic plan to develop a worldwide business in the growing and profitable fields of natural cosmetics,” said Frutarom CEO Ori Yehudai. (Reporting by Steven Scheer; Editing by Tova Cohen)
By Reuters Staff
Join 53,750 Fellow Beauty Industry Professionals
📬 Get our free weekly briefing, featuring agenda setting news & analysis on the global beauty industry.
By providing your email, you agree to our policy.